St. John's Wort Extract Ze 117 (Hypericum perforatum) Inhibits Norepinephrine and Serotonin Uptake into Rat Brain Slices and Reduces β-Adrenoceptor Numbers on Cultured Rat Brain Cells

Despite almost forty years of widespread use, the mode of action of antidepressant drugs is still largely unknown. There is agreement that these drugs interact with central neurotransmission. Common findings are acute inhibitory actions on reuptake mechanisms for norepinephrine (NE) and for serotonin (5-HT) at presynaptic axons and chronic adaptive effects on neurotransmitter receptors on postsynaptic membranes. In particular, β-adrenoceptor downregulation has been observed after chronic treatment with most antidepressants in vivo and in cell culture systems. We studied the effectiveness of Ze 117 (St. John's wort) extract (Hypericum perforatum) on NE- and 5-HT-uptake into rat brain slices. Potency and efficacy of the Ze 117 extract were compared with those of tricyclic (TCA) and selective serotonin reuptake inhibitor (SSRI)-type antidepressants. A dose-dependent inhibition was seen on NE and 5-HT uptake into brain slices. The Ze 117 extract was more selective for the uptake of NE than for that of 5-HT. The maximal extent of uptake inhibition by Ze 117 extract was comparable to that of imipramine (IMI), desipramine (DMI) or fluvoxamine for 5-HT, but lower for NE transport, than that of the synthetic antidepressants. Chronic exposure (8 days) of confluent C 6-cell cultures to Ze 117 extract resulted in a dose-dependent β-adrenoceptor downregulation equal to that induced by DMI, a potent TCA. None of these effects could be achieved with either hypericin or hyperforin alone in a relevant dose range. Our results indicate that the St. John's wort extract Ze 117 contains active, but as yet unknown antidepressant principles with effects comparable to those of TCAs.

References

• 1 Baldessarini R J. Current status of antidepressants: clinical pharmacology and therapy. J. Clin.  Psychiatry. 1989;  50 117-126
• 2 Banerjee S P, Kung L S, Riggi S J, Chanda S K. Development of β-adrenergic receptor subsensitivity by antidepressants.  Nature. 1977;  268 455-456
• 3 Bolden-Watson C, Richelson E. Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes.  Life Sci. 1993;  52 1023-1029
• 4 Daniel W A, Bickel M H, Honegger U E. The contribution of lysosomal trapping in the uptake of desipramine and chloroquine by different tissues.  Pharmacol & Toxicol. 1995;  77 402-406
• 5 De Paermentier F, Cheetham S C, Crompton M R, Katona C L, Horton R W. Brain β-adrenoceptor binding sites in depressed suicide victims effects of antidepressant treatment.  Psychopharmacol. 1991;  105 283-288
• 6 Fishman P H, Finberg J. Effect of the tricyclic antidepressant desipramine on β-adrenergic receptors in cultured rat glioma C 6 cells.  J Neurochem. 1987;  49 282-289
• 7 Heninger G R, Charney D S. Mechanisms of action of antidepressant treatments: implications for the etiology and treatment of depressive disorders.  In Meltzer, H.Y. (ed.) Psychopharmacology: The third generation of progress. New York, Raven Press 1987: 535-544
• 8 Honegger U E, Disler B, Wiesmann U N. Chronic exposure of human cells in culture to the tricyclic antidepressant desipramine reduces the number of β-adrenoceptors.  Biochem Pharmacol. 1986;  35 1899-1902
• 9 Linde K, Ramirez G, Mulrow C D, Pauls A, Weidenhammer W, Melchart D. St. John's wort for depression - an overview and metaanalysis of randomised clinical trials.  Brit Med J. 1996;  313 253-258
• 10 Manier D H, Bieck P R, Duhl D M, Gillespie D D, Sulser F. The β-adrenoceptor-coupled adenylate cyclase system in rat C 6 glioma cells. Deamplification by isoproterenol and oxaprotiline.  Neuropsychopharmacol. 1992;  7 105-112
• 11 Müller W E, Rolli M, Schäfer C, Hafner U. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.  Pharmacopsychiat. 1997;  30 (Suppl) 102-107
• 12 Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.  Pharmacopsychiat. 1998;  31 (Suppl) 16-21
• 13 Neary J T, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes.  Brain Res. 1999;  816 358-363
• 14 Papp M, Nalepa I, Vetulani J. Reversal by imipramine of β-adrenoceptor upregulation induced in a chronic mild stress model of depression.  Eur J Pharmacol. 1994 ;  261 141-147
• 15 Schildkraut J J. The catecholamine hypothesis of affective disorders: A review of supporting evidence.  Am J Psychiatry. 1965;  122 509-522
• 16 Schrader E. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild - moderate depression.  Internat Clin Psychopharmacol. 2000;  15 61-68
• 17 Zemlan F P, Garver D L. Depression and antidepressant therapy: receptor dynamics.  Prog Neuro-Psychopharmacol & Biol Psychiat. 1990;  14 503-523